Cerebral organoids: emerging ex vivo humanoid models of glioblastoma
Abstract Glioblastoma is an aggressive form of brain cancer that has seen only marginal improvements in its bleak survival outlook of 12–15 months over the last forty years. There is therefore an urgent need for the development of advanced drug screening platforms and systems that can better recapit...
Main Authors: | Michail-Dimitrios Papaioannou, Kevin Sangster, Rifat Shahriar Sajid, Ugljesa Djuric, Phedias Diamandis |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-12-01
|
Series: | Acta Neuropathologica Communications |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40478-020-01077-3 |
Similar Items
-
Organoid Models of Glioblastoma and Their Role in Drug Discovery
by: Matthew J. Rybin, et al.
Published: (2021-02-01) -
Utility of the Cerebral Organoid Glioma ‘GLICO’ Model for Screening Applications
by: Freya R. Weth, et al.
Published: (2022-12-01) -
Glioblastoma and cerebral organoids: development and analysis of an in vitro model for glioblastoma migration
by: Veronika Fedorova, et al.
Published: (2023-04-01) -
Generation of cell-type-specific proteomes of neurodevelopment from human cerebral organoids
by: Sofia Melliou, et al.
Published: (2022-12-01) -
Anti-glioblastoma activity of monensin and its analogs in an organoid model of cancer
by: Alicja Urbaniak, et al.
Published: (2022-09-01)